Skip links and keyboard navigation

Lost or stolen scheduled medicines

Licensees (manufacturers or wholesalers), clinicians and approval holders who are responsible for the manufacture, sale or distribution of scheduled medicines, are required to report discrepancies, losses or theft of these medicines to the Chief Executive, Department of Health.

Clinicians employed by Hospital and Health Services (HHS) are required to report discrepancies, losses or theft of scheduled medicines from HHS facilities to the  Chief Executive of the relevant HHS in accordance with local procedures. Contact your local Director of Pharmacy for more information if required.

For locations other than HHSs, report discrepancies, losses or theft of scheduled medicines to the Chief Executive, Department of Health using the forms below:

Reporting obligations

The following tables show who has to report discrepancies losses or theft, and they outline the relevant details and reporting requirements (as outlined in the Regulation) for:

For more information read the Health (Drugs and Poisons) Regulation 1996.

Schedule 8 (controlled drugs)

WhoSchedule 8 (controlled drugs)—what the regulation states
Licensee (manufacturer or wholesaler)

The licensee must immediately give the chief executive written notice about the discrepancy, loss, misappropriation or theft (S50A).

Institutions (private hospitals, nursing homes, detention centre, prison)

If the checker knows, or reasonably suspects, a controlled drug has been lost, misappropriated or stolen, immediately give the Chief Executive written notice about the loss, misappropriation or theft (S110).

Institutions (public hospitals)If the checker knows, or reasonably suspects, a controlled drug has been lost, misappropriated or stolen, immediately give the Chief Executive of the Hospital and Health Service written notice about the loss, misappropriation or theft (S110) in accordance with local procedures.
Certain nursing practices and Queensland Ambulance Service stations

The person must immediately report to the Chief Executive—

(a) a contravention of this regulation; or
(b) an apparently excessive use of a controlled drug; or
(c) any inconsistency between the controlled drugs in stock and the controlled drugs that the records indicate should be in stock; or
(d) if the person knows, or reasonably suspects, a controlled drug has been lost, misappropriated or stolen, the person's knowledge, or reasonable suspicion, of the loss, misappropriation or theft (S113).

Places other than an institution (dentists, doctors, nurse practitioners, veterinary surgeons, ambulance officers, indigenous health workers, midwives)

The person must immediately give the Chief Executive a written notice about the discrepancy, loss, misappropriation or theft (S116A).
Places other than an institution (community pharmacist)The person should immediately give the Chief Executive a written notice about the discrepancy, loss, misappropriation or theft.
Approval holders

As per the condition of your approval for

  • Mine sites
  • Island resorts
  • University
  • Commercial paramedic service
  • Other approvals under section 18 of the regulation (S114).

Schedule 4 (restricted drug)

WhoSchedule 4 (restricted drugs)—what the regulation states

Licensee (manufacturer or wholesaler)

If a licensee knows, or reasonably suspects that any of the following has been lost, misappropriated or stolen, the licensee must immediately give the Chief Executive a written notice about the loss, misappropriation or theft—

(a) a restricted drug that is an anabolic steroidal agent;
(b) a regulated restricted drug;

  • acitretin
  • etretinate
  • isotretinoin
  • thalidomide
  • dinoprost
  • dinoprostone
  • urofollitrophin (human follicle stimulating hormone)
  • luteinising hormone
  • clomiphene, cyclofenil or another substance specifically prepared to stimulate ovulation
  • clozapine
  • tretinoin
  • bosentan
  • bexarotene
  • teriparatide

(c) S4 pseudoephedrine (S144A).

Wholesale representative

A wholesale representative must immediately report the loss or theft of a restricted drug to the representative's employer and the nearest police establishment (S151).

Approval holders

As per the condition of your approval for

  • Mine sites
  • Island resorts
  • University
  • Commercial paramedic service
  • Animal management and/or welfare
  • Other approvals under section 18 of the regulation.

Schedule 3 (pseudoephedrine)

WhoSchedule 3 (pseudoephedrine)—what the regulation states

A person who sells S3 pseudoephedrine (e.g. pharmacist or licensees)

If a person who sells a poison that is S3 pseudoephedrine knows, or reasonably suspects, that any of the poison that is S3 pseudoephedrine has been lost, misappropriated or stolen, the person must immediately give the Chief Executive a written notice about the loss, misappropriation or theft (285B).

Last updated: 26 July 2019